Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Revenue

Lexicon Pharmaceuticals had revenue of $21.10M in the quarter ending March 31, 2026, with 1,572.11% growth. This brings the company's revenue in the last twelve months to $69.64M, up 123.12% year-over-year. In the year 2025, Lexicon Pharmaceuticals had annual revenue of $49.80M with 60.24% growth.

• Revenue (ttm): $69.64M
• Revenue Growth: +123.12%
• P/S Ratio: 14.09
• Revenue / Employee: $859,790
• Employees: 81
• Market Cap: 990.35M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.80M	18.72M	60.24%
Dec 31, 2024	31.08M	29.88M	2,481.48%
Dec 31, 2023	1.20M	1.07M	766.19%
Dec 31, 2022	139.00K	-159.00K	-53.36%
Dec 31, 2021	298.00K	-23.70M	-98.76%
Dec 31, 2020	24.00M	-298.08M	-92.55%
Dec 31, 2019	322.07M	258.86M	409.54%
Dec 31, 2018	63.21M	-28.48M	-31.06%
Dec 31, 2017	91.69M	12.43M	15.69%
Dec 31, 2016	79.26M	-50.76M	-39.04%
Dec 31, 2015	130.01M	107.16M	468.89%
Dec 31, 2014	22.85M	20.63M	928.53%
Dec 31, 2013	2.22M	1.13M	104.04%
Dec 31, 2012	1.09M	-760.00K	-41.10%
Dec 31, 2011	1.85M	-3.06M	-62.33%
Dec 31, 2010	4.91M	-5.79M	-54.13%
Dec 31, 2009	10.70M	-21.62M	-66.89%
Dec 31, 2008	32.32M	-17.80M	-35.51%
Dec 31, 2007	50.12M	-22.68M	-31.15%
Dec 31, 2006	72.80M	-2.88M	-3.81%
Dec 31, 2005	75.68M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 18, 2026

Data Sources Report a data error